# ![@ej23ny Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::3435682714.png) @ej23ny Biotech

Biotech posts on X about $xbi, $mreo, $ibb, $glmd the most. They currently have [-----] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

### Engagements: [-----] [#](/creator/twitter::3435682714/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3435682714/c:line/m:interactions.svg)

- [--] Week [------] +60%
- [--] Month [------] -50%
- [--] Months [---------] +125%
- [--] Year [---------] -17%

### Mentions: [--] [#](/creator/twitter::3435682714/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3435682714/c:line/m:posts_active.svg)

- [--] Week [--] -60%
- [--] Month [--] -17%
- [--] Months [---] +109%
- [--] Year [---] +18%

### Followers: [-----] [#](/creator/twitter::3435682714/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3435682714/c:line/m:followers.svg)

- [--] Week [-----] -0.34%
- [--] Month [-----] -0.17%
- [--] Months [-----] +8.90%
- [--] Year [-----] +12%

### CreatorRank: [---------] [#](/creator/twitter::3435682714/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3435682714/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  70.3% [cryptocurrencies](/list/cryptocurrencies)  44.55% [finance](/list/finance)  42.57% [currencies](/list/currencies)  6.93% [technology brands](/list/technology-brands)  2.97% [financial services](/list/financial-services)  1.98% [social networks](/list/social-networks)  1.98% [countries](/list/countries)  0.99%

**Social topic influence**
[$xbi](/topic/$xbi) #6, [$mreo](/topic/$mreo) #1, [$ibb](/topic/$ibb) #3, [$glmd](/topic/$glmd) #1, [$rare](/topic/$rare) #5, [$hind](/topic/$hind) #1, [$adtx](/topic/$adtx) #1, [$abp](/topic/$abp) 16.83%, [$sgbx](/topic/$sgbx) 13.86%, [$ixhl](/topic/$ixhl) 13.86%

**Top accounts mentioned or mentioned by**
[@quakerbrothers](/creator/undefined) [@bob4punk](/creator/undefined) [@idalopirdine](/creator/undefined) [@dball435](/creator/undefined) [@drrichjlaw](/creator/undefined) [@abbvie](/creator/undefined) [@javier944712106](/creator/undefined) [@liteupthedark1](/creator/undefined) [@jeromeleonard5](/creator/undefined) [@biotechiq](/creator/undefined) [@lovingpharma](/creator/undefined) [@vcu](/creator/undefined) [@iampels](/creator/undefined) [@tradesman93](/creator/undefined) [@meremrtl](/creator/undefined) [@boogeymantradez](/creator/undefined) [@mereobiopharma](/creator/undefined) [@oncxerna](/creator/undefined) [@doepkemichel](/creator/undefined) [@ltbioinvestor](/creator/undefined)

**Top assets mentioned**
[SuperRare (RARE)](/topic/$rare) [ADiTx Therapeutics, Inc. (ADTX)](/topic/$adtx) [ImmunityBio, Inc. Common Stock (IBRX)](/topic/$ibrx) [MEDIROM Healthcare Technologies Inc. (MRM)](/topic/$mrm) [Gains Network (GNS)](/topic/$gns) [XCF Global, Inc. Class A Common Stock (SAFX)](/topic/$safx) [Mingteng International Corporation Inc. (MTEN)](/topic/$mten) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Innovation Beverage Group Limited (IBG)](/topic/$ibg) [Bata (BTA)](/topic/$bta) [Oscar Health, Inc.  (OSCR)](/topic/$oscr) [KULR Technology Group, Inc. (KULR)](/topic/kulr) [Wave Life Sciences Ltd. Ordinary Shares (WVE)](/topic/$wve) [AstraZeneca PLC (AZN)](/topic/$azn) [Erayak Power Solution Group Inc. (RAYA)](/topic/$raya) [BEAM (BEAM)](/topic/$beam) [Novartis AG (NVS)](/topic/$nvs) [Opendoor Technologies Inc Common Stock (OPEN)](/topic/$open) [GSK plc (GSK)](/topic/$gsk) [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) [Intensity Therapeutics, Inc. (INTS)](/topic/$ints) [Autozi Internet Technology (Global) Ltd. (AZI)](/topic/$azi) [Reata Pharmaceuticals, Inc. Class A Common Stock (RETA)](/topic/$reta) [Chanson International Holding (CHSN)](/topic/$chsn) [Polibeli Group Ltd Class A Ordinary Shares (PLBL)](/topic/$plbl) [BioMarin Pharmaceutical, Inc. (BMRN)](/topic/$bmrn) [Vertex Protocol (VRTX)](/topic/$vrtx) [Top Wealth Group Holding Limited (TWG)](/topic/$twg) [Treasure Global Inc (TGL)](/topic/$tgl) [VCI Global Limited (VCIG)](/topic/$vcig) [Biogen Inc (BIIB)](/topic/$biib) [Insmed, Inc. (INSM)](/topic/$insm) [Asset Entities Inc. (ASST)](/topic/$asst) [Beyond Meat, Inc. (BYND)](/topic/$bynd)
### Top Social Posts
Top posts by engagements in the last [--] hours

"$AZTR its ridiculous the stock price is trading .43 even with 1000% upside the market cap still would be cheap: At $5 per share 5.2M OS roughly $26M for biotech is very cheap. $FGL $INTS $MSPR $Mbrx $MBIO $OPEN $ASST $AZTR I think they are waiting with a press release because they are close to an merger agreement or founding. This can be next 1000% stock $open $bynd $AZTR I think they are waiting with a press release because they are close to an merger agreement or founding. This can be next 1000% stock $open $bynd"  
[X Link](https://x.com/ej23ny/status/1986475604561047739)  2025-11-06T16:47Z [----] followers, [----] engagements


"$MREO $RARE NO FDA or EMA approved drug forOI.The disease is so devastating fda will face pushback from patients if the drug doesnt get approved $MLTX phase [--] VELA results were worst case scenario and still approvable drug $XBI $IBB @idalopirdine @ej23ny $MLTX will have a saleable drug; $MREO I have my doubts @idalopirdine @ej23ny $MLTX will have a saleable drug; $MREO I have my doubts"  
[X Link](https://x.com/ej23ny/status/2011153892651024821)  2026-01-13T19:10Z [----] followers, [----] engagements


"@Dball435 Alvelestat is more attractive now after BMRN discontinued"  
[X Link](https://x.com/ej23ny/status/2013684908795760760)  2026-01-20T18:47Z [----] followers, [---] engagements


"$GLMD $5.5M market cap dirt cheap The cheapest #MASH company With lead asset could be worth billion No debt and toxic warranties $19M in cash $KULR $SAFX $SRXH $SCNX $MTEN $IVP $RIME $IBRX $JTAI $GSIT $XBI $RARE $VKTX $GLMD its ridiculous low volume. Very easy to manipulate the stock price. today volume [----] $KULR $SAFX $SRXH $SCNX $MTEN $IVP $RIME $IBRX $JTAI $GSIT $XBI $RARE https://t.co/37j1OrTAcd $GLMD its ridiculous low volume. Very easy to manipulate the stock price. today volume [----] $KULR $SAFX $SRXH $SCNX $MTEN $IVP $RIME $IBRX $JTAI $GSIT $XBI $RARE https://t.co/37j1OrTAcd"  
[X Link](https://x.com/ej23ny/status/2014426689640493405)  2026-01-22T19:55Z [----] followers, [----] engagements


"$MREO $RARE probably Advocates for OI disease will push the FDA to approve a breakthrough Setrusumab. Setrusumab Good safety and strong BMD data will be enough for FDA approval and EU. $QURE $XBI $IBB Advocates for Huntingtons disease are pressing the FDA to approve a breakthrough gene therapy under Right-to-Try. The push follows data showing the treatment may significantly slow disease progression. $QURE $WVE $SRPT https://t.co/BOSeByYJV8 Advocates for Huntingtons disease are pressing the FDA to approve a breakthrough gene therapy under Right-to-Try. The push follows data showing the"  
[X Link](https://x.com/ej23ny/status/2015860123084669164)  2026-01-26T18:51Z [----] followers, [----] engagements


"$GLMD is trading well below cash on hand $3 per share: Current price .85 Cash on hand $19M Roughly $3 per share without value the pipeline $HIND $ADTX $MRNO $GLMD current stock price .81 raised $7M at average price of $2 per share. During the [--] months ended September [--] [----] we sold [-------] ordinary shares pursuant to the [----] Sales Agreement for a total net consideration of approximately $7.7 million $XBI $HIND $ADTX https://t.co/Q5OnhRQM8O $GLMD current stock price .81 raised $7M at average price of $2 per share. During the [--] months ended September [--] [----] we sold [-------] ordinary shares"  
[X Link](https://x.com/ej23ny/status/2016276932149563733)  2026-01-27T22:27Z [----] followers, [----] engagements


"$MREO $RARE WOW great summary of Bisphosphonates: -Huge safety concerns -efficiency not that good -should not be used as maintenance therapy Strength the case of Setrusumab in OI and should be approved by FDA and EU 🦴 Stopping antiresorptives in osteoporosis 🔹 Bisphosphonates Bind bone residual effect after stop BMD gain plateaus [--] yrs Drug holiday OK if LOWMOD risk Continue if: age [--] T-score [---] prior fracture Tail effect: Zoledronate Alendronate https://t.co/dXKF4lu3se 🦴 Stopping antiresorptives in osteoporosis 🔹 Bisphosphonates Bind bone residual effect after stop BMD gain plateaus"  
[X Link](https://x.com/ej23ny/status/2016722909872480676)  2026-01-29T03:59Z [----] followers, [----] engagements


"@drrichjlaw Insane valuation: $EIKN already raised $1B+ in private funding +$318M IPO almost $1.5Bn. Probably the market cap would be $2B+"  
[X Link](https://x.com/ej23ny/status/2017697516012081260)  2026-01-31T20:32Z [----] followers, [----] engagements


"$MREO unbelievable no reaction on $GSK return the rights to WVE-006 to $WVE $MREO Alvelestat should get more attention from big pharmaceuticals etc $GSK $SNY $XBI $IBB As I predicted while back $GSK would walk away from WVE-006 $WVE As I predicted while back $GSK would walk away from WVE-006 $WVE"  
[X Link](https://x.com/ej23ny/status/2018407658823291169)  2026-02-02T19:34Z [----] followers, [----] engagements


"$MREO the stock price should have been up at least 100% Alvelestate remains the 👑 WVE [----] #AATD September [----] data was well below expectations and thats why $GSK waked away Take look at my comment in September 👇 $XBI $IBB $BEAM $NTLA $VRTX $MREO $MREO 👍 great news Alvelestat Still the leader in #AATD $WVE today reported phase [--] data which wasnt good. Not surprised though $XBI $IBB $MREO $MREO 👍 great news Alvelestat Still the leader in #AATD $WVE today reported phase [--] data which wasnt good. Not surprised though $XBI $IBB"  
[X Link](https://x.com/ej23ny/status/2018412582718042554)  2026-02-02T19:53Z [----] followers, [----] engagements


"$EIKN @drrichjlaw correction 50.45M shares outstanding immediately after trading publicly The market cap would be roughly $8.5B @drrichjlaw Insane valuation: $EIKN already raised $1B+ in private funding +$318M IPO almost $1.5Bn. Probably the market cap would be $2B+ @drrichjlaw Insane valuation: $EIKN already raised $1B+ in private funding +$318M IPO almost $1.5Bn. Probably the market cap would be $2B+"  
[X Link](https://x.com/ej23ny/status/2018450829989367998)  2026-02-02T22:25Z [----] followers, [----] engagements


"@Quakerbrothers 😂 you are fixated with market cap. I told while back the current OS is around [---] -7M shares"  
[X Link](https://x.com/ej23ny/status/2022057133597171992)  2026-02-12T21:16Z [----] followers, [--] engagements


"@jeromeleonard5 Off course there is: $MREO $RARE trial was outdated with current FDA guidelines for OI $AMGN phase [--] OI trial Primary ends point Fracture BMD Z Score Secondly same story with $CMPX you was bearish and I was bullish when the was trading below $1 https://clinicaltrials.gov/study/NCT05972551term=Romosozumab%20Osteogenesis%20Imperfecta&rank=1 https://clinicaltrials.gov/study/NCT05972551term=Romosozumab%20Osteogenesis%20Imperfecta&rank=1"  
[X Link](https://x.com/ej23ny/status/2006436569205661870)  2025-12-31T18:45Z [----] followers, [---] engagements


"$GLMD patiently waiting and still holding a full position. $HIND $ADTX $MRNO $GLMD added more today $GLMD added more today"  
[X Link](https://x.com/ej23ny/status/2018371740968099905)  2026-02-02T17:11Z [----] followers, [---] engagements


"@_Biotech_iQ @Loving_pharma $MREO High risk trade at .20 Alvelestat $0 - INBX-101 augmentation therapy sold $1.7Bn Navicixizumab similar MOA as $CMPX CTX-009 (tovecimig)"  
[X Link](https://x.com/ej23ny/status/2010173245535007150)  2026-01-11T02:13Z [----] followers, [---] engagements


"$GLMD reverse split in planning absolutely not in planning. The company has [--] months to get the stock price above $1 The extremely undervalued and stock price could skyrocket any day $HIND $ADTX $MRNO $GLMD reverse split in planning $GLMD reverse split in planning"  
[X Link](https://x.com/anyuser/status/2018389554349130128)  2026-02-02T18:22Z [----] followers, [----] engagements


"$GLMD holding full position Market cap $4M is completely a joke Cash as of 09:30:25 $19M Promising Data Seen with Aramchol in Combo with TKI Showing Potential in GI and Hepatic Cancers Potentially starting open label Phase 1b trial in 1st qtr [----] $HIND $ADTX $MRNO $XBI $GLMD reverse split in planning absolutely not in planning. The company has [--] months to get the stock price above $1 The extremely undervalued and stock price could skyrocket any day $HIND $ADTX $MRNO $GLMD reverse split in planning absolutely not in planning. The company has [--] months to get the stock price above $1 The"  
[X Link](https://x.com/ej23ny/status/2019049505438494854)  2026-02-04T14:04Z [----] followers, [---] engagements


"$GLMD added more scope up dip $HIND $ADTX $MRNO $XBI $GLMD reverse split in planning absolutely not in planning. The company has [--] months to get the stock price above $1 The extremely undervalued and stock price could skyrocket any day $HIND $ADTX $MRNO $GLMD reverse split in planning absolutely not in planning. The company has [--] months to get the stock price above $1 The extremely undervalued and stock price could skyrocket any day $HIND $ADTX $MRNO"  
[X Link](https://x.com/anyuser/status/2019063832677662850)  2026-02-04T15:01Z [----] followers, [----] engagements


"$GLMD adding more .65 $HIND $ADTX $MRNO $XBI $GLMD added more scope up dip $HIND $ADTX $MRNO $XBI https://t.co/738OxkqIUM $GLMD added more scope up dip $HIND $ADTX $MRNO $XBI https://t.co/738OxkqIUM"  
[X Link](https://x.com/ej23ny/status/2019069217518113017)  2026-02-04T15:23Z [----] followers, [----] engagements


"$GLMD current price .65 : raised $7M at average price of $2 per share $HIND current price $2.35 raised $5.29M at average price of $5 per share $KULR $SAFX $SRXH $SCNX $MTEN $IVP $RIME $IBRX $JTAI $GSIT $XBI $RARE $VKTX $ADTX $GLMD current stock price .81 raised $7M at average price of $2 per share. During the [--] months ended September [--] [----] we sold [-------] ordinary shares pursuant to the [----] Sales Agreement for a total net consideration of approximately $7.7 million $XBI $HIND $ADTX https://t.co/Q5OnhRQM8O $GLMD current stock price .81 raised $7M at average price of $2 per share. During the"  
[X Link](https://x.com/ej23ny/status/2019109965387165999)  2026-02-04T18:05Z [----] followers, [----] engagements


"$GLMD adding more today. Scooping up the dip $HIND $ADTX $MRNO $XBI $GLMD adding more .65 $HIND $ADTX $MRNO $XBI https://t.co/OaJbdibXag $GLMD adding more .65 $HIND $ADTX $MRNO $XBI https://t.co/OaJbdibXag"  
[X Link](https://x.com/ej23ny/status/2019486655774683611)  2026-02-05T19:01Z [----] followers, [----] engagements


"$GLMD loaded up last couple of days: Yahoo Finance Financial Highlights of $Glmd Total Cash $19M Book Value Per Share $3.49 $KULR $SAFX $SRXH $SCNX $MTEN $IVP $RIME $IBRX $JTAI $GSIT $XBI $RARE $VKTX $ADTX $HIND $GLMD adding more today. Scooping up the dip $HIND $ADTX $MRNO $XBI https://t.co/YdJxeHjk35 $GLMD adding more today. Scooping up the dip $HIND $ADTX $MRNO $XBI https://t.co/YdJxeHjk35"  
[X Link](https://x.com/ej23ny/status/2019785403310497807)  2026-02-06T14:49Z [----] followers, [----] engagements


"$GLMD IMHO extremely high rewards at this level and low risk. Cash in hand is at least $2 yahoo has $3.49 per share $KULR $SAFX $SRXH $SCNX $MTEN $IVP $RIME $IBRX $JTAI $GSIT $XBI $RARE $VKTX $ADTX $HIND $GLMD loaded up last couple of days: Yahoo Finance Financial Highlights of $Glmd Total Cash $19M Book Value Per Share $3.49 $KULR $SAFX $SRXH $SCNX $MTEN $IVP $RIME $IBRX $JTAI $GSIT $XBI $RARE $VKTX $ADTX $HIND https://t.co/V5pc5SZLps $GLMD loaded up last couple of days: Yahoo Finance Financial Highlights of $Glmd Total Cash $19M Book Value Per Share $3.49 $KULR $SAFX $SRXH $SCNX $MTEN $IVP"  
[X Link](https://x.com/ej23ny/status/2020880655358300190)  2026-02-09T15:21Z [----] followers, [---] engagements


"$GLMD abstract published of lead asset Aramchol. Results looking promising Next step the company and sponsor is designing phase [--] trial $KULR $SAFX $SRXH $SCNX $MTEN $IVP $RIME $IBRX $JTAI $GSIT $XBI $RARE $VKTX $ADTX $HIND https://x.com/oncotarget/status/2002091681785462940s=46 🎥 #OncotargetShort: Abstract #video about this #research paper #published in Vol. [--] titled "The SCD1 inhibitor aramchol interacts with regorafenib to kill GI tumor cells in vitro and in vivo." @VCU 🔗 https://t.co/nNfAzMdKjL #cancer #TrendingWithImpact #tumors #oncology #oa https://t.co/8pOfoKuifh"  
[X Link](https://x.com/ej23ny/status/2020947973060915451)  2026-02-09T19:48Z [----] followers, [---] engagements


"My favorite low float stocks $GLMD big position on my portfolio [---] to 11M OS $HIND 6M OS $QTTB [----] OS $XBI $IBB Low float $GLMD -4% I expect reversal $HIND +22% $XBI $IBB Low float $GLMD -4% I expect reversal $HIND +22% $XBI $IBB"  
[X Link](https://x.com/ej23ny/status/2020956363405361357)  2026-02-09T20:21Z [----] followers, [----] engagements


"$MREO $RARE the data looked solid in IMHO Setrusumab hit the most important BMD And reduced fracture in children High chance of approval imho $XBI $IBB $MREO: Ultragenyx has earnings call on Feb [--]. This is the first time they will be answering a broader group of analysts about Setrusumab failure and the path forward. They now had more than a month to analyze the data so hopefully we will know the plans forward $MREO: Ultragenyx has earnings call on Feb [--]. This is the first time they will be answering a broader group of analysts about Setrusumab failure and the path forward. They now had"  
[X Link](https://x.com/ej23ny/status/2020972302322843961)  2026-02-09T21:25Z [----] followers, [----] engagements


"$MREO $RARE osteogenesis imperfecta is debilitating disease and no approved treatment The only drug that has shown promising results in OI is Setrusumab Lets hope the FDA does the right thing and approve setrusumab Its painful to watch child suffering with OI 👇 Cam kemik hastas bir bebein annesi ile oynad yatakta kayma oyunu https://t.co/tzgqOObamw Cam kemik hastas bir bebein annesi ile oynad yatakta kayma oyunu https://t.co/tzgqOObamw"  
[X Link](https://x.com/ej23ny/status/2020976324551246223)  2026-02-09T21:41Z [----] followers, [----] engagements


"$ABP 👍 THE GOLDMAN SACHS GROUP INC purchased [---------] shares representing 6.8% ownership"  
[X Link](https://x.com/ej23ny/status/2021065850497978526)  2026-02-10T03:37Z [----] followers, [----] engagements


"$MREO we will find out tomorrow Setrusumab if it path forward for filing. IMHO i think it strong possibility that they will file for approval EU approval is much easier than FDA Eu has warnings label regarding rare atypical femoral fractures caused bisphosphonate $XBI $IBB"  
[X Link](https://x.com/ej23ny/status/2021576113097474534)  2026-02-11T13:24Z [----] followers, [----] engagements


"$GLMD very low risk of dilution 6.6M OS $19M in cash As of 02/9/26 $2.8 per share vs current stock price of .65 $XBI $IBB $HIND $QTTR My favorite low float stocks $GLMD big position on my portfolio [---] to 11M OS $HIND 6M OS $QTTB [----] OS $XBI $IBB My favorite low float stocks $GLMD big position on my portfolio [---] to 11M OS $HIND 6M OS $QTTB [----] OS $XBI $IBB"  
[X Link](https://x.com/ej23ny/status/2021646210894115107)  2026-02-11T18:03Z [----] followers, [---] engagements


"As I predicted while back $GSK would walk away from WVE-006 $WVE $wve regains full rights to #RNAediting AATD program from GSK as GSK selects another target under collaboration. https://t.co/Ooxjhg7nQf $KRRO $BEAM $wve regains full rights to #RNAediting AATD program from GSK as GSK selects another target under collaboration. https://t.co/Ooxjhg7nQf $KRRO $BEAM"  
[X Link](https://x.com/ej23ny/status/2018403558220083545)  2026-02-02T19:18Z [----] followers, [----] engagements


"Low float $GLMD -4% I expect reversal $HIND +22% $XBI $IBB $GLMD current price .65 : raised $7M at average price of $2 per share $HIND current price $2.35 raised $5.29M at average price of $5 per share $KULR $SAFX $SRXH $SCNX $MTEN $IVP $RIME $IBRX $JTAI $GSIT $XBI $RARE $VKTX $ADTX https://t.co/jyRyN9erex $GLMD current price .65 : raised $7M at average price of $2 per share $HIND current price $2.35 raised $5.29M at average price of $5 per share $KULR $SAFX $SRXH $SCNX $MTEN $IVP $RIME $IBRX $JTAI $GSIT $XBI $RARE $VKTX $ADTX https://t.co/jyRyN9erex"  
[X Link](https://x.com/ej23ny/status/2019133080179765288)  2026-02-04T19:36Z [----] followers, [----] engagements


"$MREO the wheels have not fallen off yet. IMHO NDA filing in [----] and approval in [----] @ej23ny https://t.co/ppXmO02DuU @ej23ny https://t.co/ppXmO02DuU"  
[X Link](https://x.com/ej23ny/status/2021934757773537348)  2026-02-12T13:09Z [----] followers, [----] engagements


"$GLMD no debt no toxic financing Should be trading same price as $QTTB Current OS 6.6M confirmed by the company Cash in hand roughly $18M as of December [----] Phase [--] ready #MASH asset $SAFX $SRXH $SCNX $MTEN $IVP $RIME $IBRX $JTAI $GSIT $XBI $RARE $VKTX $ADTX $HIND My favorite low float stocks $GLMD big position on my portfolio [---] to 11M OS $HIND 6M OS $QTTB [----] OS $XBI $IBB My favorite low float stocks $GLMD big position on my portfolio [---] to 11M OS $HIND 6M OS $QTTB [----] OS $XBI $IBB"  
[X Link](https://x.com/ej23ny/status/2021997337959444693)  2026-02-12T17:18Z [----] followers, [----] engagements


"$GLMD text book manipulation big discrepancy between buy and sell [-----] buy order at .609 and sell at .656 $SAFX $SRXH $SCNX $MTEN $IVP $RIME $IBRX $JTAI $GSIT $XBI $RARE $VKTX $ADTX $HIND $QTTB $GLMD no debt no toxic financing Should be trading same price as $QTTB Current OS 6.6M confirmed by the company Cash in hand roughly $18M as of December [----] Phase [--] ready #MASH asset $SAFX $SRXH $SCNX $MTEN $IVP $RIME $IBRX $JTAI $GSIT $XBI $RARE $VKTX $ADTX $HIND https://t.co/D45aBEO8qV $GLMD no debt no toxic financing Should be trading same price as $QTTB Current OS 6.6M confirmed by the company"  
[X Link](https://x.com/ej23ny/status/2022031660565614889)  2026-02-12T19:34Z [----] followers, [----] engagements


"$MREO Im holding full position. I didnt sell at $5 or .20 I will continue hold it until the buy out. Rubric capital has been holding their position for 4-5 years You do you $XBI $IBB $MREO $RARE setrusumab is active drug in OI and better drug than Bisphosphonate which has been approved in [----] $XBI $IBB $MREO $RARE setrusumab is active drug in OI and better drug than Bisphosphonate which has been approved in [----] $XBI $IBB"  
[X Link](https://x.com/ej23ny/status/2011502838908674284)  2026-01-14T18:17Z [----] followers, [----] engagements


"$MREO Alvelestat pill - [--] randomized controlled Ph [--] in #AATD only small molecule succeed in mid stage in AATD No competition in oral pill after $BMRN discontinued $BMRN discards liver disease candidate after $4.8B Amicus announcement $XBI $IBB https://www.fiercebiotech.com/biotech/biomarin-quietly-discards-liver-disease-candidate-after-48b-amicus-announcement https://www.fiercebiotech.com/biotech/biomarin-quietly-discards-liver-disease-candidate-after-48b-amicus-announcement"  
[X Link](https://x.com/ej23ny/status/2013673377144193201)  2026-01-20T18:02Z [----] followers, [----] engagements


"$GLMD still long on the stock despite downtrend but the undervalued. Here are some low OS $GLMD. 6.6M OS SP .58 $HIND 5.5M OS SP $2.7 $QTTB. 12.5M OS SP $3.9 $XBI $IBB $GLMD text book manipulation big discrepancy between buy and sell [-----] buy order at .609 and sell at .656 $SAFX $SRXH $SCNX $MTEN $IVP $RIME $IBRX $JTAI $GSIT $XBI $RARE $VKTX $ADTX $HIND $QTTB https://t.co/PEaUnKc1Z1 $GLMD text book manipulation big discrepancy between buy and sell [-----] buy order at .609 and sell at .656 $SAFX $SRXH $SCNX $MTEN $IVP $RIME $IBRX $JTAI $GSIT $XBI $RARE $VKTX $ADTX $HIND $QTTB"  
[X Link](https://x.com/ej23ny/status/2022334682436935743)  2026-02-13T15:38Z [----] followers, [---] engagements


"$MREO Rubric capital filed yesterday 13F Holding full position in the company no changes Im guess that they believe the company still worth at least $5-$10 $5 the valuation would be $900m $10 the valuation would be 1.8Bn Im holding full position as well. $XBI $IBB $MREO Im holding full position. I didnt sell at $5 or .20 I will continue hold it until the buy out. Rubric capital has been holding their position for 4-5 years You do you $XBI $IBB $MREO Im holding full position. I didnt sell at $5 or .20 I will continue hold it until the buy out. Rubric capital has been holding their position for"  
[X Link](https://x.com/ej23ny/status/2022724063819444276)  2026-02-14T17:26Z [----] followers, [----] engagements


"$ABP people are selling at .17 or .18 And same people will be chasing when this goes over .50+ ABP-150 Claudin [----] gastric cancer asset will get attention from other pharmaceutical companies $IMAB valuation is getting high and $ABP is trading [--] times cheaper $XBI @ej23ny Watch them chase this when extension gets granted. Got me some 17s earlier @ej23ny Watch them chase this when extension gets granted. Got me some 17s earlier"  
[X Link](https://x.com/ej23ny/status/1978138594993684511)  2025-10-14T16:39Z [----] followers, [----] engagements


"@i_am_pels @TRADESMAN93 The deadline is October [--] to file the NDS according to their agreement between ABPRO and Celltrion"  
[X Link](https://x.com/ej23ny/status/1981395714187153477)  2025-10-23T16:22Z [----] followers, [---] engagements


"$MREO next to report phase [--] data December data readout $KYMR +51% $DYN +13% $GPCR +102% $WVE +137% $MREO to report phase [--] data imminent"  
[X Link](https://x.com/ej23ny/status/1998080469271978384)  2025-12-08T17:21Z [----] followers, [---] engagements


"$MREO $RARE another foolish tweet by male nurse @meremrtl few weeks before phase [--] results. The fracture rate was 67% in phase [--] They need 30% fractures rates to to be successful plenty of room for margin of error"  
[X Link](https://x.com/ej23ny/status/2000653489308082442)  2025-12-15T19:45Z [----] followers, [----] engagements


"$MREO $RARE huge opportunity for Setrusumab similar or higher price than Crysvita Canada Reimbursement Recommendation (Crysvita) Crysvita estimated cost the public drug approximately $287000000 over the next [--] years How much does Crysvita cost 410K-$528k per patient $MREO $RARE the biggest binary catalyst $MREO $RARE the biggest binary catalyst"  
[X Link](https://x.com/ej23ny/status/2002553193549685074)  2025-12-21T01:34Z [----] followers, [----] engagements


"$GLMD just matter of time when stock skyrocket. Holding full position Trading well below cash in hand $3.49 per share $PAVS $FULC $WKHS $CETX $TWG $TGL $VCIG $IBIO $QCLS $IRBT $SGML $NCPL $XBI $IRBT $pfsa $SGBX $GLMD reversing after a downtrend eyes on follow-through https://t.co/jORGfABM2L $GLMD reversing after a downtrend eyes on follow-through https://t.co/jORGfABM2L"  
[X Link](https://x.com/ej23ny/status/2003176955211059608)  2025-12-22T18:52Z [----] followers, [----] engagements


"$GLMD its sad what the market makers can do In [--] minutes only [---] shares traded since 9:32 $OPTX $HIHO $TRIB $VIVK $HXHX $SOC $WOK $HXHX $PAVS $FULC $WKHS $CETX $TWG $TGL $VCIG $AZI $XBI $SGBX"  
[X Link](https://x.com/ej23ny/status/2003485018660962584)  2025-12-23T15:17Z [----] followers, [----] engagements


"$GLMD still holding and I have no sold any shares. Its pathetic only [-----] shares traded today Hopefully the company will announce news January [----] $OPTX $HIHO $TRIB $VIVK $HXHX $SOC $WOK $HXHX $PAVS $FULC $WKHS $CETX $TWG $TGL $VCIG $AZI $XBI $SGBX $GLMD its sad what the market makers can do In [--] minutes only [---] shares traded since 9:32 $OPTX $HIHO $TRIB $VIVK $HXHX $SOC $WOK $HXHX $PAVS $FULC $WKHS $CETX $TWG $TGL $VCIG $AZI $XBI $SGBX $GLMD its sad what the market makers can do In [--] minutes only [---] shares traded since 9:32 $OPTX $HIHO $TRIB $VIVK $HXHX $SOC $WOK $HXHX $PAVS $FULC"  
[X Link](https://x.com/ej23ny/status/2004655020592320860)  2025-12-26T20:46Z [----] followers, [----] engagements


"$MREO 👍 Setrusumab phase [--] robust data BMD and pain improvements in OI. The stock price should continue to increase into $1-$5 and potential to buy out of $10+ $KULR $SAFX $SRXH $SCNX $MTEN $IVP $RIME $IBRX $JTAI $GSIT $XBI $RARE"  
[X Link](https://x.com/ej23ny/status/2011786567115755611)  2026-01-15T13:04Z [----] followers, [----] engagements


"$MREO volatility continues: institutional investors are loading up because data looks approvable [------] shares buys at .68 $KULR $SAFX $SRXH $SCNX $MTEN $IVP $RIME $IBRX $JTAI $GSIT $XBI $RARE $TENX $MREO 👍 Setrusumab phase [--] robust data BMD and pain improvements in OI. The stock price should continue to increase into $1-$5 and potential to buy out of $10+ $KULR $SAFX $SRXH $SCNX $MTEN $IVP $RIME $IBRX $JTAI $GSIT $XBI $RARE $MREO 👍 Setrusumab phase [--] robust data BMD and pain improvements in OI. The stock price should continue to increase into $1-$5 and potential to buy out of $10+ $KULR"  
[X Link](https://x.com/ej23ny/status/2011885083846983755)  2026-01-15T19:35Z [----] followers, [----] engagements


"$GLMD still holding full position and I have not sold any shares and Im not planning to sell any Market makers still trying to hold the stock price down $KULR $SAFX $SRXH $SCNX $MTEN $IVP $RIME $IBRX $JTAI $GSIT $XBI $RARE $GLMD waiting patiently for skyrocket like $SHPH $GLMD 5.5M OS news could come any day $XBI $IBB $GLMD waiting patiently for skyrocket like $SHPH $GLMD 5.5M OS news could come any day $XBI $IBB"  
[X Link](https://x.com/ej23ny/status/2013712177048256746)  2026-01-20T20:36Z [----] followers, [----] engagements


"$MREO its ridiculous that Alvelestat has $0 value despite good results in severe alpha-1 antitrypsin deficiency. #AATD [--] randomized controlled phase [--] trials [---] patients. -Favorable safety profile -good efficacy $WVE $Beam $prme $NTLA $XBI Eur Respir J: Alvelestat an oral neutrophil elastase (NE) inhibitor demonstrated a favourable safety profile suppressed NE and improved disease activity biomarkers when taken at [---] mg twice daily for [--] weeks in severe alpha-1 antitrypsin deficiencyhttps://t.co/LTZEC7APKl https://t.co/7cc0dJpJa8 Eur Respir J: Alvelestat an oral neutrophil elastase (NE)"  
[X Link](https://x.com/ej23ny/status/2016868728034513039)  2026-01-29T13:39Z [----] followers, [----] engagements


"@boogeymantradez Absolutely not similar $QNCX to $MREO Lucid Capital Markets double downgrades on $QNCX from $8 to $0 price target. Running out of cash"  
[X Link](https://x.com/ej23ny/status/2017584286052806933)  2026-01-31T13:02Z [----] followers, [---] engagements


"$GLMD current market cap is $4M and extremely undervalued -p [--] ready MASH drug -p 1/2 oncology asset Cash in hand /$3 per share vs current stock price of .69 $XBI $IBB $HIND $ADTX $MRNO $GLMD $6M market cap & $19.2M in cash -p [--] ready MASH drug -p 1/2 oncology asset The company trading negative enterprise value Cash in hand /$3 per share $TERN beginning of year was traded $1.87 and now trading $45 discontinued main obesity drug in October $XBI $IBB https://t.co/rIDlczsQo9 $GLMD $6M market cap & $19.2M in cash -p [--] ready MASH drug -p 1/2 oncology asset The company trading negative enterprise"  
[X Link](https://x.com/ej23ny/status/2018383247244153131)  2026-02-02T17:57Z [----] followers, [---] engagements


"@Quakerbrothers 5.6+.65 =3.6"  
[X Link](https://x.com/ej23ny/status/2019206216946446422)  2026-02-05T00:27Z [----] followers, [--] engagements


"@Quakerbrothers 😂 its not worth responding to your tweets. Yahoo has the market cap 3.47M"  
[X Link](https://x.com/ej23ny/status/2019222291553431686)  2026-02-05T01:31Z [----] followers, [--] engagements


"@Quakerbrothers EIKN was calculations error"  
[X Link](https://x.com/ej23ny/status/2019222431467204836)  2026-02-05T01:31Z [----] followers, [--] engagements


"$MREO 🤔 Burns McClellan investor & public relations representing @MereoBioPharma Also represented rare disease companies chemoCentryx $CCXI acquired by $AMGN HorizonPharma $HZNP acquired by $AMGN CinCor Pharma $CINC acquired by $AZN"  
[X Link](https://x.com/ej23ny/status/1626037864881348610)  2023-02-16T01:56Z [----] followers, [----] engagements


"2 major players in #AATD LIVER AND LUNG $MREO #AATD LUNG Disease phase [--] straight forward 12-18 months to complete the phase [--] trial $ARWR #AATD LIVER Disease phase [--] primary completion of the trial in [----] biopsy required by FDA the rest of players far behind: $NVO $VRTX $WVE $BEAM $NTLA $GSK $KRRO $MREO grand slam presentation by Kristen Kluska [--] top picks and $MREO is one of them -Underappreciated and undervalued company in universe -Very bullish on Alvelestat phase [--] in #AATD * very relaxed primary endpoints by FDA & EU $WVE $NTLA $BEAM $KRRO $CYTK $VKTX $XBI $IBB $MREO grand slam"  
[X Link](https://x.com/anyuser/status/1752423159918190754)  2024-01-30T20:06Z [----] followers, 13.3K engagements


"early stage Oncology biotech Boundless Bio files for a $100 million IPO $BOLD late stage Oncology biotech @OncXerna should file for IPO as well. $XBI $IBB"  
[X Link](https://x.com/ej23ny/status/1765851246638821410)  2024-03-07T21:25Z [----] followers, [----] engagements


"$MREO still extremly undervalued company . IMHO the company should be valued around $5bn -$7bn / $30-$40 per share $BIIB acquired $RETA for $7.2Bn ultra rare disease drug addressable market 5k people $MREO lead asset Setrusumab addressable market 50k people $XBI $IBB @doepke_michel $INSM valuation now $15Bn -$16Bn $MREO valuation now $700M @doepke_michel $INSM valuation now $15Bn -$16Bn $MREO valuation now $700M"  
[X Link](https://x.com/anyuser/status/1827000186956030265)  2024-08-23T15:09Z [----] followers, [----] engagements


"$MREO $655M mcap [--] lead drugs 1)Setrusumab TAM [-----] patients 2)Alvelestat TAM 250K -600K patients $BIIB paid $7.3B to acquire $RETA in [--] for rare disease drug Skyclarys [---] years after acquisition the revenue for Skyclarys $102M per qtr roughly $420M $XBI $NVS $AZN $BIIB - Leqembi Q3 sales $67M beat. Skyclarys $102M miss. $BIIB - Leqembi Q3 sales $67M beat. Skyclarys $102M miss"  
[X Link](https://x.com/ej23ny/status/1851671706274009202)  2024-10-30T17:05Z [----] followers, [----] engagements


"$MREO most people blame management for the stock price Remainder folks the short interest has a increased almost 100% highest Same happened to $VRNA in [----] stock price dipped $11s $reta had short interest increase before acquisition by $BIIB $XBI $IBB $MREO $460M MCAP : Ridiculous low 25X cheaper than $INSM Alvelestat - similar MOA as $INSM Brensocatib According to Baird report PH [--] READY IN #AATD potentially Future indication #COPD #Bronchiectasis $INSM $14B MCAP Brensocatib- Bronchiectasis $XBI $IBB $gsk $AZN $NVS https://t.co/vbpm2nH7L8 $MREO $460M MCAP : Ridiculous low 25X cheaper than"  
[X Link](https://x.com/ej23ny/status/1882870415607144685)  2025-01-24T19:17Z [----] followers, [----] engagements


"$MREO so many clueless and haters. if IA2 hit the company would be probably worth $2-$3Bn. I still think if Setrusumab gets approved in [----] the BO price target should be similar to $RETA $XBI $IBB @LTbioinvestor $mreo will be under $1 by next week absolute carnage @LTbioinvestor $mreo will be under $1 by next week absolute carnage"  
[X Link](https://x.com/ej23ny/status/1910299953554989375)  2025-04-10T11:52Z [----] followers, [----] engagements


"$MREO 05/14/2025 $JHG Janus Henderson Group filed an 3G/A disclosing ownership of [--------] represents 14.3% ownership of Mereo added [-------] shares from 1-1-2025 thru 03-31-2025 $XBI $IBB $ARDX $NVS $AZN $RARE $MREO is cooking with gas. Janus Henderson 🔥 https://t.co/htVdRbkXpR $MREO is cooking with gas. Janus Henderson 🔥 https://t.co/htVdRbkXpR"  
[X Link](https://x.com/ej23ny/status/1923077653055033442)  2025-05-15T18:06Z [----] followers, [----] engagements


"$MREO $ARDX $JHG Janus Henderson Group disclosing ownership in 03/31/2025 $MREO [--------] shares represents 14.3% ownership added [-------] shares $ARDX [--------] shares represents 10.48% ownership $XBI $IBB $MREO 05/14/2025 $JHG Janus Henderson Group filed an 3G/A disclosing ownership of [--------] represents 14.3% ownership of Mereo added [-------] shares from 1-1-2025 thru 03-31-2025 $XBI $IBB $ARDX $NVS $AZN $RARE https://t.co/PodO2AzTNW $MREO 05/14/2025 $JHG Janus Henderson Group filed an 3G/A disclosing ownership of [--------] represents 14.3% ownership of Mereo added [-------] shares from 1-1-2025"  
[X Link](https://x.com/ej23ny/status/1923096605734916101)  2025-05-15T19:22Z [----] followers, [----] engagements


"$ABP July presentation IND submission news could be announced any day for lead asset ABP-102/CT-P72 partnered to Celltrion for $1.75Bn $XBI $VAPE $IXHL $SNGX $FDMT https://investor.abpro.co/static-files/ca2377f6-c67b-4db1-a6e8-e8ddbe07280f $ABP the main reason for yesterday and today decline 👇 the .19 discord folks are taking profits today. The rest of folks like me at .27 holding for the next leg up +.50 -$1s hopefully. Just my [--] cents $XBI $VAPE $IXHL $SNGX https://investor.abpro.co/static-files/ca2377f6-c67b-4db1-a6e8-e8ddbe07280f $ABP the main reason for yesterday and today decline 👇"  
[X Link](https://x.com/ej23ny/status/1951222998951928213)  2025-08-01T10:06Z [----] followers, [----] engagements


"$ABP $15M maket cap -$1.75Bn partnership with big pharm celltrion and lead asset CT-P72is fully funded by celltrion $ABP is trading [--] times cheaper than $ATNF which is ridiculous $IXHL $BTA $MRM $NCNA $LPSN $SGBX $IBG $TPIC $NLSP $OSCR $GNS $RAYA $CHSN $ABP $PLBL $RYVL $XBI FULL LIST OF STOCKS THAT CAN RUN 50-100%+ NEXT WEEK OR HAS CONTINUED MOMENTUM 🚨📈 #1 $IXHL #2 $BTAI #3 $MRM #4 $NCNA #5 $LPSN #6 $SGBX #7 $IBG #8 $TPIC #9 $NLSP #10 $OSCR #11 $GNS #12 $RAYA $CHSN #13 $ABP #14 $PLBL #15 $AUUD #16 $RYVL #17 $BMNR #18 $DKI Anything else FULL LIST OF STOCKS THAT CAN RUN 50-100%+ NEXT WEEK OR"  
[X Link](https://x.com/ej23ny/status/1955261602816491873)  2025-08-12T13:34Z [----] followers, 11.4K engagements


"$ABP $16M market cap Developing ABP-150 Claudin [----] in Gastric cancer $IMAB stock price increased from .60 to $5.90 based on givastomig Claudin18.2 asset in gastric cancer $IXHL $MRM $LPSN $BSLK $GNS $Xbi $OPEN $CARM $ORIS $GSIW $RAYA $ADAP $ATCH $Bini $LPTX $INTS $IMAB -Leerink initiates I-Mab coverage at Outperform $9 target - $INN -Baird lowers Summit Hotel target to $4.50 from $5 Neutral - $INSM -Goldman Sachs raises Insmed stock to $196 from $121 Buy - $IVZ -BMO initiates Invesco coverage at Outperform $28 target - $IMAB -Leerink initiates I-Mab coverage at Outperform $9 target - $INN"  
[X Link](https://x.com/ej23ny/status/1976370576798458251)  2025-10-09T19:33Z [----] followers, [----] engagements


"$ABP Maxim group new report today. While we remain positive on the potential of Abpro's bispecific antibody portfolio including ABP-102 (HER2 x CD3m partnered with Celltrion and ABP-201 (VEGF x ANG2) the strategic direction of these programs remains unclear $BYND $AIRE $ABP since April without news Boom or bust god know the best. Im hoping for boom 💥 agree that $AIR and $BYND to spark penny stocks under $1 $ABP since April without news Boom or bust god know the best. Im hoping for boom 💥 agree that $AIR and $BYND to spark penny stocks under $1"  
[X Link](https://x.com/ej23ny/status/1980731319840829861)  2025-10-21T20:22Z [----] followers, [----] engagements


"$AZTR if the they announced good news we could see potential bigger upside than $INTS 500% Keep in mind $AZTR float is 3.5M OS and no S1 in filed. No public offering $MSPR $INTS $MBRX $FGL $VNRX $MBIO $FGL $ALPS $AZTR avg Analysts rating is $4 per share represent potentially 852% upside. $MSPR $INTS $MBRX $FGL $VNRX $MBIO https://t.co/Z5TU2apgfQ $AZTR avg Analysts rating is $4 per share represent potentially 852% upside. $MSPR $INTS $MBRX $FGL $VNRX $MBIO https://t.co/Z5TU2apgfQ"  
[X Link](https://x.com/ej23ny/status/1986496709963260317)  2025-11-06T18:11Z [----] followers, [----] engagements


"$AZTR reported good quarter. No public offering because they already have $20M in financing"  
[X Link](https://x.com/ej23ny/status/1988750794758467877)  2025-11-12T23:28Z [----] followers, [----] engagements


"@idalopirdine 👍. Unfortunately people are bullish on $MLTX NDA and bearish on $MREO NDA which doesnt make any sense to me. They are so many folks who are clueless interpreting the data"  
[X Link](https://x.com/ej23ny/status/2011141222702907858)  2026-01-13T18:20Z [----] followers, [---] engagements


"@brandy117 @bob4punk $PCYC acquired for 21B for [--] asset tyrosine kinase Imbruvica blockbuster approved for blood cancer. Which is not a curative therapy. $ATNM [--] programs that have potential curative therapies. 1) GeneTx & Cell therapy etc $SRPT (12B) 2) BMT 3) CAR-T 4) AWE Tech Focus blood cancer"  
[X Link](https://x.com/ej23ny/status/1289743936060133377)  2020-08-02T02:04Z [----] followers, [--] engagements


"$tomdf Todos Medical Announces $23760000 Contract for COVID-19 PCR Testing Equipment @AbbottLab @ExactSciences $abt $exas $srne $aytu #COVID19 #covid #pennystocks #otcstocks $ibio $htbx $nvax $mrna https://www.streetinsider.com/dr/news.phpid=17305873 https://www.streetinsider.com/dr/news.phpid=17305873"  
[X Link](https://x.com/ej23ny/status/1300406822008950786)  2020-08-31T12:15Z [----] followers, [--] engagements


"@biggercapital @bob4punk Agreed Blockbuster potential curative therapies & sadly tremendously undervalued. People will regret it in December after positive phase [--] data. $atnm has all the potential to be the next $PCYC"  
[X Link](https://x.com/ej23ny/status/1313988187245678592)  2020-10-07T23:42Z [----] followers, [--] engagements


"@COILPOD @bob4punk @GermanBiotech @AstraZeneca @Novartis $FUNS pipeline is more focused on solid tumors because its not effective targeting liquid tumors. $Fusn is looking to improve their ac225 by collaborating with Canadas company TRIUMF. Bottom line $ATNM has the best alpha-emitting isotope with a short half-life & very effective"  
[X Link](https://x.com/ej23ny/status/1339410849530867712)  2020-12-17T03:23Z [----] followers, [--] engagements


"@OrbiMed $MREO partner $RARE presented impressive presentation on Setrusumab $MREO will Receive up to $254M for clinical regulatory and commercial milestones +double digit royalties on net sales in US.Mereo retains rights to setrusumab in EU&UK potential value +500M $XBI $IBB"  
[X Link](https://x.com/ej23ny/status/1613217377780436997)  2023-01-11T16:52Z [----] followers, 33.2K engagements


"$MREO $137M MC 1) Setrusumab bone disease drug huge market opportunity 2) Alvelestate in #AATD lung disease bigger market than Cystic Fibrosis Vs $CINC $1.3B valuation only [--] drug Baxdrostate missed the primary endpoint in phase [--] $AZN should have acquired $MREO for $1B"  
[X Link](https://x.com/ej23ny/status/1626260073482682375)  2023-02-16T16:39Z [----] followers, [----] engagements


"$MREO multiple interim analysis built into the trial most likely the trial will be stopped early than primary completion date of 03/2025. The fracture rate reduction 3X and the trial overpowered will result early stoppage $XBI $IBB 1/ A few interesting notes on Setrusumab following the $RARE conference call relevant to $MREO: A few of the questions were regarding the timing on the two ORBIT interim analysis and Emil hasnt been very forthcoming but seems to have finally given some details. 1/ A few interesting notes on Setrusumab following the $RARE conference call relevant to $MREO: A few of"  
[X Link](https://x.com/ej23ny/status/1720413009309257935)  2023-11-03T12:09Z [----] followers, [----] engagements


"$IPN $IPSEY ACQUIRED bone disease company $CMTA FOR $1.3bn palovarotene approved for rare bone disease that impacts about [---] people in the U.S. Very small market size $MREO Setrusumab IMPACTS 30K patients in EU and should be worth minimum $1.5Bn/ $10 per share +1.5X the current price of $4 $XBI $IBB $NVS $AZN $MREO - Even at $12.00 or $1.7B the company is cheap relative to rare disease buyouts. The table below highlights some recent rare disease takeouts. We have TWO (2) Billion $$ drugs in pipeline. Clementia Pharma was closely similar to Mereo as they too had a bone drug like"  
[X Link](https://x.com/ej23ny/status/1753127069863616610)  2024-02-01T18:43Z [----] followers, [----] engagements


"$MREO hired new VP Head of Legal experienced in M&A. She was VP Head of Legal $ALBO who was acquired by $IPSEY for +$1Bn. I wonder Why would MEREO hire experienced M&A lawyer now unless they are negotiating offer $NTLA $BEAM $CYTK $VKTX $XBI $IBB $SNY $NVS $AZN $INZY $ARDX $XBI $IBB $NVO $MOR $FDMT $AUPH $SNAP $GILD $SMMT $exel $lly $vktx https://twitter.com/i/web/status/1755981054580494784 https://twitter.com/i/web/status/1755981054580494784"  
[X Link](https://x.com/ej23ny/status/1755981054580494784)  2024-02-09T15:44Z [----] followers, 10.7K engagements


"$MREO speachless that the stock price is stuck $3s Despite postive news on #TIGIT -Just #TIGIT asset alone could be worth at least $5 per share Phase 1/2 etigilimab #TIGIT in combination with nivolumab in select recurrent advanced / metastatic solid tumors -impressive clinical efficacy and deep durable responses Great video by Principal Investigator of ACTIVATE a Phase 1b/2 basket etigilimab #TIGIT in combination with nivolumab $XBI $IBB $NVS $ITOS $BGNE https://www.onclive.com/view/dr-mckean-on-the-activate-study-in-solid-tumors-and-pd-l1-low-disease Piper $ITOS Remain buyers based potential"  
[X Link](https://x.com/ej23ny/status/1765758530265489676)  2024-03-07T15:16Z [----] followers, [----] engagements


"$ABP buying accumulation continues [-----] shares buy order $IXHL $BTA $MRM $NCNA $LPSN $SGBX $IBG $TPIC $NLSP $OSCR $GNS $RAYA $CHSN $ABP $PLBL $RYVL $XBI $ATNF $ABP $15M maket cap -$1.75Bn partnership with big pharm celltrion and lead asset CT-P72is fully funded by celltrion $ABP is trading [--] times cheaper than $ATNF which is ridiculous $IXHL $BTA $MRM $NCNA $LPSN $SGBX $IBG $TPIC $NLSP $OSCR $GNS $RAYA $CHSN $ABP $PLBL $RYVL $XBI https://t.co/W5f9unRQ3Y $ABP $15M maket cap -$1.75Bn partnership with big pharm celltrion and lead asset CT-P72is fully funded by celltrion $ABP is trading 60"  
[X Link](https://x.com/ej23ny/status/1955269184364900727)  2025-08-12T14:04Z [----] followers, [----] engagements


"$ABP near break out & price target $4 1500% upside potential IMO PR soon 2nd qtr earnings is due by August [--] $IXHL $BTA $MRM $NCNA $LPSN $SGBX $IBG $TPIC $NLSP $OSCR $GNS $RAYA $CHSN $ABP $PLBL $RYVL $XBI $BSLK $ABP When PR drop this will be a runner IMO $ABP When PR drop this will be a runner IMO"  
[X Link](https://x.com/ej23ny/status/1955698377594712301)  2025-08-13T18:30Z [----] followers, 12K engagements


"$ABP risky but massive upside potential [--] Week High/Low. $13/.156 $IXHL $BTA $MRM $NCNA $LPSN $SGBX $IBG $TPIC $NLSP $OSCR $GNS $RAYA $CHSN $ABP $PLBL $RYVL $XBI $BSLK $ABP near break out & price target $4 1500% upside potential IMO PR soon 2nd qtr earnings is due by August [--] $IXHL $BTA $MRM $NCNA $LPSN $SGBX $IBG $TPIC $NLSP $OSCR $GNS $RAYA $CHSN $ABP $PLBL $RYVL $XBI $BSLK https://t.co/hPSIAz6ojA $ABP near break out & price target $4 1500% upside potential IMO PR soon 2nd qtr earnings is due by August [--] $IXHL $BTA $MRM $NCNA $LPSN $SGBX $IBG $TPIC $NLSP $OSCR $GNS $RAYA $CHSN $ABP $PLBL"  
[X Link](https://x.com/ej23ny/status/1956062883269214592)  2025-08-14T18:38Z [----] followers, [----] engagements


"$ABP T-cell engager asset very valuable. current market cap of $22M is ridiculously low @AbbVie pens $1B deal for Simceres phase [--] T-cell engager $IXHL $BTA $MRM $NCNA $LPSN $SGBX $IBG $TPIC $NLSP $OSCR $GNS $BINI $XBI https://www.fiercebiotech.com/biotech/jpm25-abbvie-pens-1b-deal-simceres-phase-1-t-cell-engager $ABP the stock price should be trading $4 just on $ABBV Acquisition of Capstan Therapeutics @abbvie acquisition of Capstan Therapeutics for up to $2.1 billion great news for vivo CAR-T space stocks like $ABP $IXHL $BTA $MRM $NCNA $LPSN $SGBX $IBG $TPIC $NLSP $OSCR $GNS"  
[X Link](https://x.com/ej23ny/status/1957819269783208208)  2025-08-19T14:57Z [----] followers, [----] engagements


"$ABP will be great target for big pharms. the valuation is dirt cheap @AbbVie 2nd deal for T-cell engager pays $65M with $1.4B chaserfor options on @evolveimmune T-cell engagers $IXHL $BTA $MRM $NCNA $LPSN $SGBX $IBG $TPIC $NLSP $OSCR $GNS $BINI $XBI https://www.fiercebiotech.com/biotech/abbvie-pays-65m-14b-chaser-options-evolveimmunes-t-cell-engagers https://www.fiercebiotech.com/biotech/abbvie-pays-65m-14b-chaser-options-evolveimmunes-t-cell-engagers"  
[X Link](https://x.com/ej23ny/status/1957827382036857021)  2025-08-19T15:29Z [----] followers, [----] engagements


"$ABP +$3 acquisition price is bargain for big pharmaceuticals @GileadSciences to acquire Interius BioTherapeutics private company for $350M $IXHL $BTA $MRM $NCNA $LPSN $SGBX $IBG $TPIC $NLSP $OSCR $GNS $BINI $XBI $ABP $19M market cap: developing CAR T-cell therapy: valuation is ridiculously low Abpro pipeline is more advanced than Interius 👇 $GiLD / Kite to Acquire CAR T cell therapy Interius BioTherapeutics private company for $350M. $XBI $IXHL $OPEN $APM $PTIX $CYCU $GNS https://t.co/ckbRvFi7aQ $ABP $19M market cap: developing CAR T-cell therapy: valuation is ridiculously low Abpro"  
[X Link](https://x.com/ej23ny/status/1958948029068648749)  2025-08-22T17:43Z [----] followers, [----] engagements


"$ABP 5X the current price $1.25 it seems high but valuation still remains dirt cheap Maxim group price target $4 $IXHL $BTA $MRM $NCNA $LPSN $SGBX $IBG $TPIC $NLSP $OSCR $GNS $BINI $XBI The Only Four Stocks You Need To 5x Your Account (Next Weeks Watchlist) 🚨 Lets see how fast we can get to [---] likes ❤ https://t.co/MA0gIXHVHX https://t.co/iOoLooV6NK The Only Four Stocks You Need To 5x Your Account (Next Weeks Watchlist) 🚨 Lets see how fast we can get to [---] likes ❤ https://t.co/MA0gIXHVHX https://t.co/iOoLooV6NK"  
[X Link](https://x.com/ej23ny/status/1960041840696311822)  2025-08-25T18:09Z [----] followers, [----] engagements


"$ABP gone through [--] page of Form PRE 14A filed on 08/29/25 Im more bullish than before and stock price should have been up@ least 100% today im holding full position: you do you $IXHL $BTA $MRM $NCNA $LPSN $SGBX $IBG $TPIC $NLSP $OSCR $GNS $BINI $XBI https://investor.abpro.co/static-files/ab2a751b-219f-4cb7-a116-57a4b0bd2122 $ABP stock price should be up by a lot today: RS margins 1/10 the lowest margin that I have seen for pennies stocks: the annual meeting would not be for another 45-60 days: $CARM + 150% shares holders approved RS in 1/50 margin. $XBI $IXHL $HOTH"  
[X Link](https://x.com/ej23ny/status/1962914411091312835)  2025-09-02T16:23Z [----] followers, [----] engagements


"$ABP strong finish today: hopefully ready for next leg up. $IXHL $BTA $MRM $NCNA $LPSN $SGBX $IBG $TPIC $NLSP $OSCR $GNS $BINI $XBI $ABP gone through [--] page of Form PRE 14A filed on 08/29/25 Im more bullish than before and stock price should have been up@ least 100% today https://t.co/EHcfGGxN0c im holding full position: you do you $IXHL $BTA $MRM $NCNA $LPSN $SGBX $IBG $TPIC $NLSP $OSCR $GNS $BINI $XBI $ABP gone through [--] page of Form PRE 14A filed on 08/29/25 Im more bullish than before and stock price should have been up@ least 100% today https://t.co/EHcfGGxN0c im holding full position:"  
[X Link](https://x.com/ej23ny/status/1963335015174914119)  2025-09-03T20:15Z [----] followers, [----] engagements


"$ABP there are many possible ways Positive: 1)Merger with another company 2)Potential selling the company 3)cost savings Negative delay on IND filing IMHO I view this positive and Im not selling Good luck though $IXHL $MRM $bini $LPSN $BSLK $IBG $lptx $XBI $ABP 👍 Chief Medical Officer terminated: On September [--] [----] Abpro Holdings Inc. furloughed Chief Medical Officer Robert J. Markelewicz Jr. effective until November [--] [----] at which point his employment will terminate https://t.co/n28PhhJoiP $IXHL $lptx $Xbi $raya $ABP 👍 Chief Medical Officer terminated: On September [--] [----] Abpro"  
[X Link](https://x.com/ej23ny/status/1973853280016216177)  2025-10-02T20:51Z [----] followers, [----] engagements


"$ABP stock price .1815 $15m MCAP $IMAB stock price $6 $700 MCAP $IMAB Givastomig Claudin 18.2- gastric cancer $ABP -ABP-150 Claudin [----] gastric cancer Both target the same proteinsClaudin [----] on tumor cells and 4-1BB or CD3 on T-cell $XBI $LPTX $IXHL $AZI $ABP $16M market cap Developing ABP-150 Claudin [----] in Gastric cancer $IMAB stock price increased from .60 to $5.90 based on givastomig Claudin18.2 asset in gastric cancer $IXHL $MRM $LPSN $BSLK $GNS $Xbi $OPEN $CARM $ORIS $GSIW $RAYA $ADAP $ATCH $Bini $LPTX $INTS https://t.co/8FxiIqyqQQ $ABP $16M market cap Developing ABP-150 Claudin"  
[X Link](https://x.com/ej23ny/status/1977760395159834662)  2025-10-13T15:36Z [----] followers, [----] engagements


"$GLMD great 3rd quarter *current price .84 vs $3.49 valuation * $4.5M market cap * $19.2M in cash /5.5M OS $3.49 per share $EPSM $ASST $GNS $AZI $EPWK $BULL $smx $glto $amix $VEEE $FGL $SBEV $ADTX $JAGX $SGBX $KALA $XBI"  
[X Link](https://x.com/ej23ny/status/1993713026315497904)  2025-11-26T16:06Z [----] followers, [---] engagements


"$MDGL @MadrigalPharma should acquire $GLMD @GalmedPharma for $100M $GLMD secured new patents for the Aramchol with Rezdiffra combination in #MASH $GLMD plans to engage with (FDA) on designing a Phase [--] trial for this combination $XBI $IBB $DVLT $GUTS $IVF $OPEN It appears that $MDGL will remain an independent company and build a pipeline behind Rezdiffra. The launch of the first MASH drug speaks for itself and the company's sales force. The price tag is simply too high but I like the company even without M&A deal. 👇 https://t.co/lkC5H5Ey8J It appears that $MDGL will remain an independent"  
[X Link](https://x.com/ej23ny/status/2009624435217637877)  2026-01-09T13:52Z [----] followers, [----] engagements


"$MREO Lead the pack in #AATD space & discontinuation continues terminated/discontinued Drugs in #AATD $VRTX discontinued VX-864/VX-814 $ALNY ALN-AAT02 $CNTA $NTLA NTLA3001 $BMRN latest victim 12/2025 Remaining companies AATD $MREO PH [--] ready $BEAM data in [--] $XBI $IBB $MREO Lead the pack in AATD space terminated/discontinued Drugs in #AATD $VRTX discontinued VX-864/VX-814 $ALNY ALN-AAT02 $CNTA $NTLA NTLA3001 Remaining companies AATD $MREO PH [--] initiation in [--] $BEAM data in [--] $WVE Data in [--] $KRRO Data in [--] $KRYS Data in [--] $XBI $MREO Lead the pack in AATD space terminated/discontinued"  
[X Link](https://x.com/ej23ny/status/2011521950376452474)  2026-01-14T19:32Z [----] followers, [---] engagements


"$CMPX hit [--] weeks high today $6.14: I feel bad for folks who sold it $1.90: I guess next @ej23ny Sold $cmpx 190$ for a slight profit. Turned bearish for good reasons. And that ORR drop on topline proved me right. Didn't think they would still hit stat sig below [--] tbh. No regrets as it wasn't worth the risk. They'll also need to run another P3 imo. Wait for it. @ej23ny Sold $cmpx 190$ for a slight profit. Turned bearish for good reasons. And that ORR drop on topline proved me right. Didn't think they would still hit stat sig below [--] tbh. No regrets as it wasn't worth the risk. They'll also"  
[X Link](https://x.com/ej23ny/status/2011564429499121811)  2026-01-14T22:21Z [----] followers, [----] engagements


"$GLMD Im shocked that stock price is .80 Late stage asset in MASH and phase [--] open label data shown 60% fibrosis reduction oral pill is good data. Potentially a billion drug and current market cap is $6M Patent granted for combo with $MDGL $XBI $ADTX $ENTA $IBB $GLMD Excellent article that nails exactly where GLMD stands right now. So if you want to update your GLMD knowledge or get acquainted with GLMD this is a must read. https://t.co/DSMVbpMwZv $GLMD Excellent article that nails exactly where GLMD stands right now. So if you want to update your GLMD knowledge or get acquainted with GLMD"  
[X Link](https://x.com/ej23ny/status/2013997049167986939)  2026-01-21T15:28Z [----] followers, [----] engagements


"$MREO $86M market cap High risk 1) Alvelestat $0 - INBX-101 augmentation therapy sold $1.7Bn 2) Navicixizumab similar MOA as $CMPX CTX-009 (tovecimig) valued +$1B $XBI $IBB $MREO Why it could bounce back Oversold: Technical RSI at extreme lows. Strategic Pivot: Focus moving to Alvelestat Burn Rate: extends survival to [----]. M&A target for larger players interested in rare disease IP. High risk but look decoupled from the remaining assets. 🧪💎 $MREO Why it could bounce back Oversold: Technical RSI at extreme lows. Strategic Pivot: Focus moving to Alvelestat Burn Rate: extends survival to"  
[X Link](https://x.com/ej23ny/status/2014063860982919498)  2026-01-21T19:53Z [----] followers, [----] engagements


"$GLMD current stock price .81 raised $7M at average price of $2 per share. During the [--] months ended September [--] [----] we sold [-------] ordinary shares pursuant to the [----] Sales Agreement for a total net consideration of approximately $7.7 million $XBI $HIND $ADTX Extremely tiny float stocks: #1 $GLMD current price .82 $19M in cash as of 3rd qtr/ $3 per share #2 $HIND current price. $3 $5.71M in cash Both companies potentially have billion dollar drug I will give $GLMD hedge over $HIND because of strong balance sheet and no debt Extremely tiny float stocks: #1 $GLMD current price .82 $19M in"  
[X Link](https://x.com/ej23ny/status/2016206872475279519)  2026-01-27T17:49Z [----] followers, [----] engagements


"$GLMD volume started to increase: 15K buy order $XBI $ENTA $GPCR $IBRX $ADTX $HIND $rimi $CRDF"  
[X Link](https://x.com/ej23ny/status/2016953325300646194)  2026-01-29T19:15Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing